When molecular BC subtypes were considered in the UALCAN dataset, CDCA5 high expression was seen in the HER2-enriched and TNBC molecular classes more than the luminal A (estrogen receptor (ER)-positive/progesterone receptor (PR)-positive (ER+/PR+) class (Figure 1B). This evidence concerns the gene CDCA5 and breast cancer.